these results suggest that the insensitivity of the a-cell to hyperglycemia exists after treatment , and this abnormal plasma glucagon response to glucose after treatment may be caused either by impaired response of endogenous insulin to glucose , which is sustained even after treatment , or by an intrinsic defect of the a-cell .
C0020456
hyperglycemia
C0021641
insulin